Zobrazeno 1 - 10
of 106
pro vyhledávání: '"Andreas Greinacher"'
Autor:
Delcea M; Mihaela Delcea, PhD, ZIK HIKE - Zentrum für Innovationskompetenz, 'Humorale Immunreaktionen bei kardiovaskulären Erkrankungen', Ernst-Moritz-Arndt-Universität Greifswald, Fleischmannstrasse 42-44, 17489 Greifswald, Germany, Tel.: +49 3834 8622343, E-mail: delceam@uni-greifswald.de., Greinacher A; Prof. Dr. med. Andreas Greinacher, MD, Institut für Immunologie und Transfusionsmedizin, Sauerbruchstrasse, 17475 Greifswald, Germany, Tel.: +49 3834 865482, E-mail: greinach@uni-greifswald.de.
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 2016 Oct 28; Vol. 116 (5), pp. 783-791. Date of Electronic Publication: 2016 Sep 22.
Autor:
Krauel K, Schulze A, Jouni R, Hackbarth C, Hietkamp B, Selleng S, Koster A, Jensch I, van der Linde J, Schwertz H, Bakchoul T, Hundt M, Greinacher A; Prof. Dr. Andreas Greinacher, Institut für Immunologie und Transfusionsmedizin, Universitätsmedizin Greifswald, Ferdinand-Sauerbruch-Strasse, D-17489 Greifswald, Germany, Tel.: +49 3834 865482, Fax: +49 3834 865489, E-mail: greinach@uni-greifswald.de.
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 2016 Apr; Vol. 115 (4), pp. 752-61. Date of Electronic Publication: 2015 Oct 15.
Autor:
Brandt S, Krauel K, Jaax M, Renné T, Helm CA, Hammerschmidt S, Delcea M; Mihaela Delcea, PhD, ZIK HIKE - Zentrum für Innovationskompetenz, 'Humorale Immunreaktionen bei kardiovaskulären Erkrankungen', Ernst-Moritz-Arndt-Universität Greifswald, Fleischmannstrasse 42-44, 17489 Greifswald, Germany, Tel.: +49 3834 8622343, E-mail: delceam@uni-greifswald.de., Greinacher A; Prof. Dr. med. Andreas Greinacher, MD, Institut für Immunologie und Transfusionsmedizin, Sauerbruchstrasse, 17475 Greifswald, Germany, Tel.: +49 3834 865482, E-mail: greinach@uni-greifswald.de.
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 2015 Nov 25; Vol. 114 (6), pp. 1189-98. Date of Electronic Publication: 2015 Jul 30.
Autor:
Brandt S, Krauel K, Gottschalk KE, Renné T, Helm CA, Greinacher A; Prof. Dr. med. Andreas Greinacher, Institut für Immunologie und Transfusionsmedizin, Sauerbruchstrasse, 17475 Greifswald, Germany, Tel.: +49 3834 865482, Fax: +49 3834 865489, E-mail: greinach@uni-greifswald.de., Block S; Stephan Block, PhD, Applied Physics, Chalmers University of Technology, Fysikgränd 3, S-412 96 Gothenburg, Sweden, E-mail: block@physik.uni-greifswald.de, stephan.block@chalmers.se.
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 2014 Jul 03; Vol. 112 (1), pp. 53-64. Date of Electronic Publication: 2014 Mar 27.
Autor:
Medvedev N, Palankar R, Krauel K, Greinacher A; Prof. Dr. med. Andreas Greinacher, MD, Institut für Immunologie und Transfusionsmedizin, Sauerbruchstrasse, 17475 Greifswald, Germany, Tel: +49 3834 865482, Fax: +49 3834 865489, e-mail: greinach@uni-greifswald.de., Delcea M; Mihaela Delcea, PhD, ZIK HIKE - Zentrum für Innovationskompetenz, 'Humorale Immunreaktionen bei kardiovaskulären Erkrankungen', Ernst-Moritz-Arndt-Universität Greifswald, Fleischmannstrasse 42-44, 17489 Greifswald, Germany, Tel.: +49 3834 8622343, Fax: +49 3834 8622341, E-mail: delceam@uni-greifswald.de.
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 2014 May 05; Vol. 111 (5), pp. 862-72. Date of Electronic Publication: 2014 Jan 23.
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 19, p 6126 (2023)
An effective worldwide vaccination campaign started and is still being carried out in the face of the coronavirus disease 2019 (COVID-19) pandemic. While vaccines are great tools to confront the pandemic, predominantly adenoviral vector-based vaccine
Externí odkaz:
https://doaj.org/article/0842997494ad40459f02865d98349223
Publikováno v:
Cells, Vol 11, Iss 10, p 1615 (2022)
Platelet adhesion and spreading at the sites of vascular injury is vital to hemostasis. As an integral part of the innate immune system, platelets interact with opsonized bacterial pathogens through FcγRIIA and contribute to host defense. As mechano
Externí odkaz:
https://doaj.org/article/a3135a1e23cb48419527ef91e1817b7c
Autor:
Jason B. Giles, Heidi E. Steiner, Jerome Rollin, Christian M. Shaffer, Yukihide Momozawa, Taisei Mushiroda, Chihiro Inai, Kathleen Selleng, Thomas Thiele, Claire Pouplard, Nancy M. Heddle, Michiaki Kubo, Elise C. Miller, Kiana L. Martinez, Elizabeth J. Phillips, Theodore E. Warkentin, Yves Gruel, Andreas Greinacher, Dan M. Roden, Jason H. Karnes
Publikováno v:
Blood Advances. 6:4137-4146
Heparin, a widely used anticoagulant, carries the risk of an antibody-mediated adverse drug reaction, heparin-induced thrombocytopenia (HIT). A subset of heparin-treated patients produces detectable levels of antibodies against complexes of heparin b
Autor:
Andreas Greinacher, Linda Schönborn, Florian Siegerist, Leif Steil, Raghavendra Palankar, Stefan Handtke, Alexander Reder, Thomas Thiele, Konstanze Aurich, Karen Methling, Michael Lalk, Uwe Völker, Nicole Endlich
Publikováno v:
Seminars in Hematology. 59:97-107
Vaccine-induced immune thrombotic thrombocytopenia (VITT; synonym, thrombosis with thrombocytopenia syndrome, is associated with high-titer immunoglobulin G antibodies directed against platelet factor 4 (PF4). These antibodies activate platelets via
Publikováno v:
Seminars in Hematology. 59:80-88
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a highly prothrombotic disorder that like heparin-induced thrombocytopenia (HIT) is caused by platelet-activating antibodies that recognize platelet factor 4 (PF4). However, unlike HIT-wher